Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Lexeo Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +31 vs. Q3 2023
- Shares held
- 16.2M
- +16.2M vs. Q3 2023
- Total value
- $217.1M
- +$217.1M vs. Q3 2023
- New holders
- 31
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 141 | $410.9M |
| Q1 2026 | 139 | $458.7M |
| Q4 2025 | 146 | $759.2M |
| Q3 2025 | 109 | $327.5M |
| Q2 2025 | 90 | $169.9M |
| Q1 2025 | 88 | $100.0M |
| Q4 2024 | 90 | $194.2M |
| Q3 2024 | 69 | $268.8M |
| Q2 2024 | 60 | $426.3M |
| Q1 2024 | 54 | $361.5M |
| Q4 2023 | 31 | $217.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Lexeo Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 72 | $966 | 0.00% | +72 | New |
| JPMorgan Chase & Co | 112 | $1.50K | 0.00% | +112 | New |
| Steward Partners Investment Advisory, LLC | 323 | $4.33K | 0.00% | +323 | New |
| Qube Research & Technologies Ltd | 603 | $8.09K | 0.00% | +603 | New |
| Tower Research Capital LLC (TRC) | 1,490 | $20.0K | 0.00% | +1,490 | New |
| Bank of America Corp | 8,128 | $109.1K | 0.00% | +8,128 | New |
| Morgan Stanley | 9,488 | $127.3K | 0.00% | +9,488 | New |
| Caxton Corp | 10,319 | $138.5K | 0.75% | +10,319 | New |
| Bank of New York Mellon Corp | 14,110 | $189.4K | 0.00% | +14,110 | New |
| Legal & General Group Plc | 15,000 | $202.4K | 0.00% | +15,000 | New |
| Barclays PLC | 15,517 | $208.2K | 0.00% | +15,517 | New |
| Northern Trust Corp | 15,589 | $209.2K | 0.00% | +15,589 | New |
| Cubist Systematic Strategies, LLC | 25,750 | $345.6K | 0.00% | +25,750 | New |
| Point72 Middle East FZE | 28,578 | $383.5K | 0.03% | +28,578 | New |
| ExodusPoint Capital Management, LP | 34,172 | $459.0K | 0.01% | +34,172 | New |
| Jane Street Group, LLC | 38,960 | $522.8K | 0.00% | +38,960 | New |
| Millennium Management LLC | 44,100 | $591.8K | 0.00% | +44,100 | New |
| Citigroup Inc | 91,889 | $1.23M | 0.00% | +91,889 | New |
| Geode Capital Management, LLC | 100,421 | $1.35M | 0.00% | +100,421 | New |
| BlackRock Inc. | 169,896 | $2.28M | 0.00% | +169,896 | New |
| Verition Fund Management LLC | 189,062 | $2.54M | 0.03% | +189,062 | New |
| Laurion Capital Management LP | 255,301 | $3.43M | 0.12% | +255,301 | New |
| Vanguard Group Inc | 416,182 | $5.59M | 0.00% | +416,182 | New |
| Artal Group S.A. | 603,435 | $8.10M | 0.28% | +603,435 | New |
| Blackstone Group Inc. | 696,110 | $9.34M | 0.04% | +696,110 | New |
| Novo Holdings A/S | 1,307,829 | $17.6M | 1.17% | +1,307,829 | New |
| Citadel Advisors LLC | 2,084,245 | $28.0M | 0.03% | +2,084,245 | New |
| Omega Fund Management, LLC | 2,157,623 | $29.0M | 23.46% | +2,157,623 | New |
| Janus Henderson Group PLC | 2,330,738 | $31.3M | 0.02% | +2,330,738 | New |
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 2,506,607 | $33.6M | 0.59% | +2,506,607 | New |
| Eventide Asset Management, LLC | 3,002,831 | $40.3M | 0.66% | +3,002,831 | New |